Cacquevel M, Aeschbach L, Houacine J, Fraering PC.
Alzheimer's disease-linked mutations in presenilin-1 result in a drastic loss of activity in purified γ-secretase complexes.
PLoS One. 2012;7(4):e35133.
Please login to recommend the paper.
Make a Comment
If it turns out that FAD mutations are generally loss of function, then the phenotype of haploinsufficiency would be the same as partial inhibition with γ-secretase inhibitors. Is this is why γ-secretase inhibitors failed in Phase 3? Maybe degrading APPβ CTF is a good thing?
To make a comment you must login or register.